US Stock IR Daily – August 20, 2026 (5 reports)

• Deere & Company issued a press release announcing its results of operations for the third quarter of fiscal year 2026 on Thursday, August 20, 2026.
• The announcement was filed with the SEC as a Form 8-K.
• A copy of the press release and supplemental financial information was furnished as Exhibit 99.1 to the filing.
• A presentation providing a review of its third quarter of fiscal year 2026, in connection with its investor earnings call, was furnished as Exhibit 99.2.

Deere & Company’s latest announcement signals the regular disclosure of its quarterly financial performance, providing current insights into the company’s operational and financial health. The availability of the press release and investor presentation suggests that stakeholders now have access to detailed information to assess the company’s recent results. This could be viewed as a standard step for publicly traded companies to maintain transparency with the market and its investors.

• Walmart Inc. (WMT) filed a Form 8-K on August 20, 2026.
• The company announced it would issue a press release and post a financial presentation on its website (http://stock.walmart.com) on August 20, 2026.
• These documents will disclose information regarding the company’s results of operations and cash flows for the three and six months ended July 31, 2026, and its financial condition as of July 31, 2026.
• The information provided under Item 2.02 of this Form 8-K is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934.

This 8-K filing serves as a procedural announcement for Walmart’s upcoming earnings release. The forthcoming press release and financial presentation are expected to provide investors with detailed insights into the company’s operational performance and financial health for the recently concluded periods. Key financial metrics such as revenue, profitability, and cash flow will be important for stakeholders to review to understand the company’s trajectory.

• Capital One Financial Corporation announced it will redeem all outstanding shares of its Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, Series M ($0.01 par value per share).
• The redemption date for the Series M Preferred Stock is September 1, 2026.
• The redemption price will be $1,000 per share of Series M Preferred Stock.
• All 1,000,000 outstanding shares of the Series M Preferred Stock will be redeemed.
• Regular dividends on Series M Preferred Stock will be paid separately on the redemption date to holders of record as of the close of business on August 17, 2026.
• On and after the redemption date, all dividends on Series M Preferred Stock will cease to accrue.

Capital One Financial’s announcement to redeem its Series M Preferred Stock indicates a change in its capital structure. Such redemptions may suggest the company is optimizing its financing costs or reorganizing its liabilities. For current holders of Series M Preferred Stock, this action means their principal will be returned, and dividend accrual will cease, potentially prompting a re-evaluation of their investment strategy.

• Abbott Laboratories announced on August 20, 2026, the settlement of a portion of its litigation involving specialty formulas for preterm infants.
• The settlement addresses the Gill lawsuit, where a jury awarded $495 million in damages in July 2024, and subsequent appeals.
• Abbott entered into agreements to resolve the Gill lawsuit and NEC claims asserted on behalf of approximately 2,000 additional infants for an aggregate amount of approximately $670 million.
• The company stated these agreements are a constructive step toward substantially resolving the overall litigation and not an admission of liability.
• Following these agreements, approximately 1,700 lawsuits are still pending in federal and state courts, involving claims on behalf of approximately 12,700 individual infants.

This announcement suggests Abbott Laboratories is actively addressing a significant portion of its legal challenges related to preterm infant formula. Resolving a prominent verdict and a substantial number of related claims could mitigate some of the financial and operational uncertainties for the company. Investors may continue to monitor developments regarding the remaining approximately 12,700 individual infant claims.

• Intercontinental Exchange, Inc. (ICE) completed a public offering and issuance of $3.75 billion aggregate principal amount of senior notes on August 20, 2026.
• The notes issued include $1.25 billion of 4.700% Senior Notes due 2029, $1.10 billion of 4.900% Senior Notes due 2031, $650 million of 5.150% Senior Notes due 2033, and $750 million of 5.400% Senior Notes due 2036.
• ICE received approximately $3.71 billion in net proceeds from the sale of the notes, after underwriting discounts and commissions and before offering expenses.
• ICE intends to use these net proceeds, along with anticipated borrowings and other funds, to finance the purchase price for MarketAxess Holdings Inc., as announced on July 30, 2026, and to cover related fees and expenses.
• The notes were sold pursuant to an Underwriting Agreement dated August 11, 2026, with BofA Securities, Inc. and other representatives of the underwriters.

This announcement signals Intercontinental Exchange’s concrete progress in securing financing for its previously announced acquisition of MarketAxess Holdings Inc. The successful completion of a substantial senior notes offering indicates a critical step towards funding this strategic acquisition. Investors may want to monitor how this funding impacts ICE’s balance sheet and how the integration of MarketAxess progresses, potentially shaping future growth trajectories.